Navigation Links
FDA Approves MiddleBrook's Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
Date:1/24/2008

million. For pediatricians, amoxicillin is the most prescribed drug among all therapeutic classes. Among family physicians, amoxicillin is the twelfth most prescribed drug among all therapeutic classes.

The most commonly prescribed treatment for the management of Group A streptococcal pharyngitis is 500 milligrams of amoxicillin dosed three-times daily for a period of 10 days. With the FDA approval of MOXATAG, physicians now have available the first once-daily product in the aminopenicillin class for the treatment of pharyngitis while utilizing approximately one-half the amount of amoxicillin currently used.

About pharyngitis/tonsillitis:

Pharyngitis is a painful inflammation of the throat caused by a variety of microorganisms, both viral and bacterial. About 15 million patients annually seek relief of sore throat symptoms in the United States. The most common bacterial cause of acute pharyngitis is Streptococcus pyogenes, or Group A streptococcus, which is referred to as "strep throat." Symptoms of strep throat include fever, painful swallowing, swelling of the throat, and headache. Symptomatic strep throat can lead to complications, such as rheumatic fever, and should be treated with antibiotic therapy. Pharyngitis ranks in the top ten diagnoses made by pediatricians, family physicians, and emergency medicine specialists.

About Middlebrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibi
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
2. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
3. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
4. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
5. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
6. Forest Laboratories, Inc. Announces Positive Results of LEXAPRO(R) Phase III Study in Adolescents With Major Depression
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. New Data Show Unacceptably Low Adult Immunization Rates and That Adults Unaware of Infectious Disease Threat
9. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
10. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
11. Five-Year Data Demonstrate Long-Term Efficacy and Safety with ORENCIA(R) (abatacept) in Adults with Rheumatoid Arthritis Who had an Inadequate Response to Methotrexate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...iveries are Transported ,, PHILADELPHIA, Dec....loyed by the Philadelphia chapter of the American ...out the unfair labor conditions that they endure t...ply at risk. More than 100 employees went on stri...ssues were ignored by their employer. ,, Red Cr...
(Date:12/4/2009)...re-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC...rst patient has been enrolled in the company,s Pha...rland for use of Oxycyte(TM) emulsion in traumatic...luorocarbon (PFC) therapeutic oxygen carrier. ,...ving the outcome of patients with severe TBI. We h...
(Date:12/4/2009)...wswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex:...ountermeasures against biological and chemical thr... from the Company,s anthrax vaccine program showin...gen (rPA) based anthrax vaccine is structurally st...tures up to and including 55 degrees C. The data ...
Breaking Medicine Technology:Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2Oxygen Biotherapeutics, Inc. Enrolls First Patient in Traumatic Brain Injury Clinical Trial in Switzerland 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5ACS Technologies 28TM 29 Selects M2SYS for Innovative Biometric Software 9220 1ACS Technologies 28TM 29 Selects M2SYS for Innovative Biometric Software 9220 2US Government Places 6 1 Million USD Orders Related to Precise Match on Card 28TM 29 for Cyber Security Programs 9217 1US Government Places 6 1 Million USD Orders Related to Precise Match on Card 28TM 29 for Cyber Security Programs 9217 2Type of Knee Surgery Makes Difference in Football Career 51400 1Type of Knee Surgery Makes Difference in Football Career 51400 2
...rapeutics,(Alternext: ALEHT) is pleased to announc...und in Alzheimer,s disease, is progressing well. P... EHT 0202 in patients with,Alzheimer,s disease is ...ient enrolment for the Phase IIa,represents an imp...nd,provides a clear timeline for the release of re...
...ket Share Leader Through 2017, According to a New ..., Feb. 25 Decision Resources, one of the world,s ...ical and healthcare issues, finds that a therapy,s...e attribute that most influences surveyed cardiolo...yocardial infarction (NSTEMI). Data and the opinio...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 2Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI 3
(Date:12/4/2009)...ire/ -- Pamela Bowen, Chief Information Officer at...or the "Chief Innovation Officer" Appy Award for t...cloud computing. Appy Award recipients are nominat...RM or the Force.com platform in bringing new level...artner, service, support or IT organizations. ,...
(Date:12/4/2009)...kins publishing in the December issue of Neoplasi... "Twist" may be the proverbial red flag that can a...sive, metastatic breast cancer from other breast c...g that it is a relatively rare subgroup of stem ce...ientists have surmised that this subgroup of cells...
(Date:12/4/2009)...ly or 3 weeks later, study shows , , FRI... repair or reconstruction of multiple-ligament kne...tudy has found. , Multiple-ligament knee injuri...n occur in high-impact car crashes or in certain s...ir these injuries hasn,t been definitively establi...
(Date:12/4/2009)...tient groups , , FRIDAY, Dec. 4 (HealthD...wing sarcomas and central nervous system tumors, c... have found. , The study authors analyzed data ... pediatric cancers who were enrolled in the Childh...und that the overall cancer recurrence rate was 4....
(Date:12/4/2009)...owth after heart attack , , FRIDAY, Dec....help repair heart attack damage, a new study shows... stem cells from donor bone marrow promoted the gr...by heart attack. , The patients received the st...t attack. During follow-up, they were compared to ...
Breaking Medicine News(10 mins):Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...is a plea on behalf of the HIV positive people of ... their lifetime and after death. Malsawmdawnga who...DS// Society (MPLAS) gave a press talk stating tha... practice of sealing the dead bodies of AIDS patie...
...en an increasing tendency by citizens of Scotland ...ealthy trend were to continue, it would mean a les...e a public ban on smoking the following year. ...compared to the figures in 2003 where merely 40,00...
...rala):A couple who were HIV (Human Immuno-deficien...ill their last breath in Palakkad district of Kera...t before taking this decision and decided not to p...marriage received full support from family, friend...
...a HIV positive mother, who gave birth to HIV negat...ent to provide drugs, information and clean water ...h to HIV negative childs. Auwalu has started an or...event the transmssion of her virus to her child wi...
... the World AIDS day, the Andhra Pradesh State AIDS... Indian Industry (CII) organized an AIDS awareness...ool and // colleges and various corporate and NG...at by 2010 more than 75 million people will be inf...
...ling Asia and causing havoc the bird flu has sprea...have been detected in Ukraine. This has sent p... To ascertain the severity of the flu tests ...lled for by the Ukrainian president in some parts ...
Other Medicine News:Health News:Conditions Of The HIV/AIDS Patients In The Mizo Society 2Health News:Couple infected with HIV marry in Kerala 2
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: